Article
Multidisciplinary Sciences
Miyeun Han, Hye Won Lee, Han Cheol Lee, Hyo Jin Kim, Eun Young Seong, Sang Heon Song
Summary: The study found that a low Onodera's prognostic nutritional index (PNI) was associated with acute kidney injury and mortality following PCI, potentially impacting patient survival rates.
SCIENTIFIC REPORTS
(2021)
Article
Cardiac & Cardiovascular Systems
Carlo Andrea Pivato, Davis Jones, Davide Cao, Samantha Sartori, Mauro Chiarito, Johny Nicolas, Zhongjie Zhang, Frans Beerkens, Matteo Nardin, Hanbo Qiu, Victor Razuk, Daniel Feldman, Vaishali Kumaraguru, Giulio G. Stefanini, Joseph Sweeny, Usman Baber, George Dangas, Samin K. Sharma, Annapoorna Kini, Roxana Mehran
Summary: Elevated levels of high sensitivity C-reactive protein (hsCRP) after percutaneous coronary intervention (PCI) is associated with worse ischemic outcomes, including all-cause mortality, in both diabetic and nondiabetic patients. Inflammation, indicated by high hsCRP levels, may increase cardiovascular risk independent of diabetes status.
CANADIAN JOURNAL OF CARDIOLOGY
(2022)
Article
Medical Laboratory Technology
Hui-Wen Zhang, Yuan-Lin Guo, Na-Qiong Wu, Cheng-Gang Zhu, Qian Dong, Jing Sun, Ke- Fei Dou, Jian-Jun Li
Summary: The level of low-density lipoprotein-triglyceride (LDL-TG) is associated with cardiovascular events (CVEs) in patients with chronic coronary syndrome (CCS) receiving percutaneous coronary intervention (PCI), especially in combination with high-sensitivity C-reactive protein (hs-CRP) concentrations.
CLINICA CHIMICA ACTA
(2023)
Article
Immunology
Yehong Liu, Ting Ye, Liang Chen, Baida Xu, Gangyong Wu, Gangjun Zong
Summary: The lymphocyte-to-C-reactive protein ratio (LCR) is associated with major adverse cardiovascular events (MACEs) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention. Preoperative LCR serves as a valuable prognostic marker for predicting in-hospital and long-term MACEs.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2023)
Review
Cardiac & Cardiovascular Systems
Shijie Liu, Hongcheng Jiang, Menaka Dhuromsingh, Lei Dai, Yue Jiang, Hesong Zeng
Summary: C-reactive protein (CRP) plays a significant role in predicting the prognosis of patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI). This meta-analysis suggests that elevated CRP levels are associated with adverse post-infarction outcomes, including all-cause mortality, cardiovascular death, and major adverse cardiovascular events. Furthermore, CRP shows better predictive performance for hospitalization and short-term prognosis, and Asian patients with elevated CRP are at higher risk of adverse prognosis after PCI compared to Europeans.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Pernille Gro Thrane, Kevin Kris Warnakula Olesen, Troels Thim, Christine Gyldenkerne, Martin Bodtker Mortensen, Steen Dalby Kristensen, Michael Maeng
Summary: In Western Denmark, the implementation of primary percutaneous coronary intervention (pPCI) for ST-segment elevation myocardial infarction (STEMI) has led to a significant reduction in 1-year mortality, with the greatest decline occurring within the first 30 days after pPCI. This highlights the importance of optimizing early management for improving overall survival in STEMI patients.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Article
Immunology
Zhicheng Gao, Jiaqi Bao, Liuyang Wu, Kaiyu Shen, Qiqi Yan, Lifang Ye, Lihong Wang
Summary: LCR before surgery was found to be associated with the incidence of NOAF in patients with AMI after PCI. In addition to LCR, age, body mass index, diabetes, serum albumin levels, uric acid levels, left atrial diameter, left ventricular ejection fraction, left circumflex artery stenosis, and Killip class II were independent predictors of NOAF after AMI.
JOURNAL OF INFLAMMATION RESEARCH
(2023)
Article
Cardiac & Cardiovascular Systems
Lele Cheng, Zixuan Meng, Qi Wang, Zhijie Jian, Pengcheng Fan, Xinxin Feng, Xiangrui Qiao, Jian Yang, Zuyi Yuan, Bolin Li, Yue Wu
Summary: Inflammation and nutrition significantly impact prognosis in patients with CTO undergoing PCI, with CAR values improving predictive value for all-cause death and cardiovascular death. Adding CAR values to traditional prediction models enhances prognosis prediction capacity.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Jun Gu, Zhao-fang Yin, Zuo-jun Xu, Yu-qi Fan, Chang-qian Wang, Jun-feng Zhang
Summary: This study showed that after PCI, the predominant subtype of HF is HFpEF, and higher BNP levels, lower eGFR levels, and atrial fibrillation are independent risk factors for new-onset HF. Being male and being prescribed with ACEI/ARB medications are negative predictors for new-onset HF. Additionally, long-term ACEI/ARB therapy is associated with reduced risks of developing all three subtypes of HF (HFrEF, HFmrEF, and HFpEF), compared to beta-blocker use.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Davis Jones, Alessandro Spirito, Samantha Sartori, Kenneth F. Smith, Carlo Andrea Pivato, Mauro Chiarito, Davide Cao, Johny Nicolas, Frans Beerkens, Madison Edens, Brunna Pileggi, Ananya Sen, Zhongjie Zhang, Birgit Vogel, Joseph Sweeny, Usman Baber, George Dangas, Samin K. Sharma, Annapoorna Kini, Roxana Mehran
Summary: In patients with chronic kidney disease undergoing percutaneous coronary intervention, elevated hs-CRP levels were not associated with an increased risk of major adverse cardiac events at 1 year, but were consistently associated with increased mortality hazards in both CKD and non-CKD patients.
JOURNAL OF CARDIOLOGY
(2023)
Article
Medicine, General & Internal
Si-Si Zhang, Wen-Yi Hu, Yi-Jing Li, Juan Yu, Shang Sang, Zakareya M. Alsalman, Da-Qi Xie
Summary: This study investigates the association between lp(a) variability and mean CRP levels in patients undergoing percutaneous coronary intervention (PCI). The results show that lp(a) variability is positively correlated with mean follow-up CRP level, suggesting that high variability can be considered an independent risk factor for increased post-PCI CRP level.
WORLD JOURNAL OF CLINICAL CASES
(2022)
Article
Medicine, General & Internal
Chunfeng Dai, Muyin Liu, You Zhou, Danbo Lu, Zhangwei Chen, Juying Qian, Junbo Ge
Summary: This study aimed to investigate whether aortic valve calcification (AVC) identified by transthoracic echocardiography could be a predictor of long-term adverse events after primary percutaneous coronary intervention (PCI) in patients with acute myocardial infarction. The results showed that the presence of AVC independently increased the risk of major adverse cardiovascular and cerebral events (MACCE) in patients with acute myocardial infarction after primary PCI. This imaging feature can contribute to better risk stratification in this population.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
(2022)
Article
Cardiac & Cardiovascular Systems
Yong-Hoon Yoon, Jung-Min Ahn, Do-Yoon Kang, Pil Hyung Lee, Soo-Jin Kang, Duk-Woo Park, Seung-Whan Lee, Young-Hak Kim, Ki Hoon Han, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park
Summary: Elevated levels of Lp(a) were significantly associated with recurrent ischemic events in patients undergoing PCI, suggesting the need for clinical outcome trials to test Lp(a)-lowering therapy in this population.
JACC-CARDIOVASCULAR INTERVENTIONS
(2021)
Article
Biochemistry & Molecular Biology
Zeng-Lei Zhang, Qian-Qian Guo, Jun-Nan Tang, Jian-Chao Zhang, Meng-Die Cheng, Feng-Hua Song, Zhi-Yu Liu, Kai Wang, Li-Zhu Jiang, Lei Fan, Xiao-Ting Yue, Yan Bai, Xin-Ya Dai, Ru-Jie Zheng, Ying-Ying Zheng, Jin-Ying Zhang
Summary: This study suggests that the monocyte-to-albumin ratio (MAR) may serve as an important indicator for long-term prognosis in patients undergoing PCI, with higher MAR associated with increased risk of mortality.
BIOSCIENCE REPORTS
(2021)
Article
Peripheral Vascular Disease
Jie Yang, Chen Li, Yitian Zheng, Jun Gao, Yu Peng Liu, Jing Jia Wang, Jing Jing Song, Qing Zhou, Xiangbin Meng, Kuo Zhang, Wenyao Wang, Chunli Shao, Yi-Da Tang
Summary: Limited studies have focused on the impact of high-sensitivity C-reactive protein to albumin ratio (CAR) on cardiovascular outcomes in patients undergoing percutaneous coronary intervention. This study found that CAR is an independent predictor of major adverse cardiovascular and cerebrovascular events (MACCE) and myocardial infarction (MI) in CHD patients undergoing drug-eluting stent implantation.
Editorial Material
Cardiac & Cardiovascular Systems
James Muller, Patrick Serruys, Niel Grubb, John Pastore
EUROPEAN HEART JOURNAL
(2023)
Article
Cardiac & Cardiovascular Systems
Kai Ninomiya, Patrick W. Serruys, Scot Garg, Shinichiro Masuda, Shigetaka Kageyama, Nozomi Kotoku, Marie Angele Morel, Charles Taylor, John D. Puskas, Jagat Narula, Ulrich Schneider, Torsten Doenst, Kaoru Tanaka, Johan De Mey, Mark La Meir, Saima Mushtaq, Antonio L. Bartorelli, Giulio Pompilio, Daniele Andreini, Yoshinobu Onuma
Summary: The feasibility of using CCTA and FFRCT as guidance in the FASTTRACK CABG trial is determined by the need for invasive coronary angiography. According to the SS-2020, the first 57 patients enrolled in the trial received the appropriate revascularization modality, and the DSMB allowed the investigators to continue the study.
CARDIOVASCULAR REVASCULARIZATION MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Kamil Bujak, Pablo Vidal-Cales, Rami Gabani, Riccardo Rinaldi, Josep Gomez-Lara, Luis Ortega-Paz, Victor Jimenez-Diaz, Marcelo Jimenez-Kockar, Pilar Jimenez-Quevedo, Roberto Diletti, Gianluca Campo, Antonio Silvestro, Jaume Maristany, Xacobe Flores, Loreto Oyarzabal, Antonio De Miguel-Castro, Andres Iniguez, Luis Nombela-Franco, Alfonso Ielasi, Maurizio Tespili, Mattie Lenzen, Simone Biscaglia, Soheil Al-Shaiban, Rafael Romaguera, Joan Antoni Gomez-Hospital, Mariusz Gasior, Patrick W. Serruys, Manel Sabate, Salvatore Brugaletta
Summary: This study aims to analyze the relationship between total stent length (TSL) and 10-year target-lesion failure (TLF) in patients with ST-elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention. The results show that there is a direct relationship between TSL and the risk of TLF at 10 years, mainly driven by target lesion revascularization (TLR).
AMERICAN HEART JOURNAL
(2023)
Article
Cardiac & Cardiovascular Systems
Felice Gragnano, Roxana Mehran, Mattia Branca, Anna Franzone, Usman Baber, Yangsoo Jang, Takeshi Kimura, Joo-Yong Hahn, Qiang Zhao, Stephan Windecker, Charles M. Gibson, Byeong-Keuk Kim, Hirotoshi Watanabe, Young Bin Song, Yunpeng Zhu, Pascal Vranckx, Shamir Mehta, Sung-Jin Hong, Kenji Ando, Hyeon-Cheol Gwon, Paolo Calabro, Patrick W. Serruys, George D. Dangas, Eugene P. McFadden, Dominick J. Angiolillo, Dik Heg, Marco Valgimigli
Summary: This study suggests that P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention (PCI) can preserve ischemic protection while limiting bleeding risk. Compared with dual antiplatelet therapy (DAPT), P2Y12 inhibitor monotherapy after 1-month to 3-month DAPT can reduce the major bleeding risk in complex PCI patients.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Editorial Material
Cardiac & Cardiovascular Systems
Tsung-Ying Tsai, Shigetaka Kageyama, Fabio Ramponi, Jagat Narula, Charles Taylor, Adam Updegrove, Scot Garg, Yoshinobu Onuma, Patrick W. Serruys, John Puskas
Article
Cardiac & Cardiovascular Systems
Hesham Elzomor, Timotheus J. Neumann, Linus Boas, Philipp Ruile, Mahmoud Abdelshafy, Ahmed Elkoumy, Pruthvi C. Revaiah, Tsung-Ying Tsai, Klaus Kaier, Osama Soliman, Miroslaw Ferenc, Dirk Westermann, Franz-Josef Neumann, Patrick Serruys, Simon Schoechlin
Summary: Background estimation of regurgitant fraction using videodensitometry (VD-AR) is a new objective grading tool for paravalvular regurgitation (PVR) after transcatheter aortic valve implantation (TAVI). This study found that VD-AR > 17% was independently associated with 3-year mortality. Compared to subjective visual evaluation, VD-AR resulted in a smaller proportion of patients classified as prognostically relevant for PVR.
CLINICAL RESEARCH IN CARDIOLOGY
(2023)
Editorial Material
Cardiac & Cardiovascular Systems
Patrick W. Serruys, Pruthvi C. Revaiah, Yoshinobu Onuma
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2023)
Article
Cardiac & Cardiovascular Systems
Pruthvi C. Revaiah, Patrick W. Serruys, Denise P. Yates, Yoshinobu Onuma, Jose Luis Zamorano
Summary: This article reports on the use of CCTA to non-invasively risk stratify and guide further management of patients with non-obstructive CAD. In the case presented, CCTA showed lipid-rich plaques in the left main stem and left anterior descending arteries, and the patient remained asymptomatic after treatment. The discussion highlights the value of CCTA as a diagnostic tool for assisting in the diagnosis and treatment of patients with non-obstructive CAD.
EUROPEAN HEART JOURNAL-CASE REPORTS
(2023)
Article
Cardiac & Cardiovascular Systems
Shinichiro Masuda, Patrick W. Serruys, Shigetaka Kageyama, Nozomi Kotoku, Kai Ninomiya, Scot Garg, Alan Soo, Marie-Angele Morel, John D. Puskas, Jagat Narula, Ulrich Schneider, Torsten Doenst, Kaoru Tanaka, Johan de Mey, Mark La Meir, Antonio L. Bartorelli, Saima Mushtaq, Giulio Pompilio, Daniele Andreini, Yoshinobu Onuma
Summary: This study compared treatment recommendations based on the SYNTAX score 2020 derived from coronary computed tomography angiography (CCTA) and invasive coronary angiography (ICA). The results showed moderate to substantial agreement between the anatomical SYNTAX scores derived from CCTA and ICA, suggesting that CCTA could be used as an alternative to ICA when making decisions regarding the modality of revascularization.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
(2023)
Article
Cardiac & Cardiovascular Systems
Nozomi Kotoku, Patrick W. Serruys, Kai Ninomiya, Alan Soo, Shinichiro Masuda, Shigetaka Kageyama, Pruthvi C. Revaiah, Michael J. Mack, David R. Holmes, Marie -Claude Morice, Piroze M. Davierwala, Friedrich W. Mohr, Milan Milojevic, Arie Pieter Kappetein, Scot Garg, Yoshinobu Onuma
Summary: This study aimed to evaluate the impact of non-fatal periprocedural major adverse events (PMAE) on 10-year mortality and investigate whether PMAE affect mortality predicted by SYNTAX score II 2020 (SSII-2020) and whether optimal medical therapy (OMT) has a positive effect on the prognosis of patients with non-fatal PMAE. The results show that non-fatal PMAE are more common following CABG than PCI, but their prognostic impact is similar, being significant in the first year and then diminishing out to 10 years. Therefore, patients with non-fatal PMAE may require more careful follow-up and additional preventive treatment in the first year post-procedure.
Meeting Abstract
Cardiac & Cardiovascular Systems
Kai Ninomiya, Shigetaka Kageyama, Hiroki Shiomi, Nozomi Kotoku, Shinichiro Masuda, Pruthvi Revaiah, Scot Garg, Neil O'leary, Takeshi Kimura, Yoshinobu Onuma, Patrick Serruys, Patrick Serruys
JACC-CARDIOVASCULAR INTERVENTIONS
(2023)
Meeting Abstract
Cardiac & Cardiovascular Systems
Pruthvi Chenniganahosahalli Revaiah, Asishkumar Mandalay, Gunasekaran Sengottuvelu, Ahmed Elkoumy, Hesham Elzomor, Mahmoud Abdelshafy, Sanjeev Bhatt, Yoshinobu Onuma, Osama Soliman, Patrick W. Serruys
JACC-CARDIOVASCULAR INTERVENTIONS
(2023)
Meeting Abstract
Cardiac & Cardiovascular Systems
Pruthvi Chenniganahosahalli Revaiah, Gregg W. Stone, Shinichiro Masuda, Kai Ninomiya, Nozomi Kotoku, Shigetaka Kageyama, Yoshinobu Onuma, Patrick W. Serruys
JACC-CARDIOVASCULAR INTERVENTIONS
(2023)
Meeting Abstract
Cardiac & Cardiovascular Systems
Patrick Serruys, Kai Ninomiya, Jinying Zhou, Nozomi Kotoku, Shigetaka Kageyama, Shinichiro Masuda, Yoshinobu Onuma
JACC-CARDIOVASCULAR INTERVENTIONS
(2023)
Meeting Abstract
Cardiac & Cardiovascular Systems
TsungYing Tsai, Shigetaka Kageyama, Yoshinobu Onuma, Giulio Pompilio, Daniele Andreini, Saima Mushtaq, Gianluca Pontone, Gianluca Pontone, Mark La Meir, Johan De Mey, Kaoru Tanaka, Torsten Doenst, Ulf Teichgraeber, Ulf Teichgraeber, Ulrich Schneider, John Puskas, Jagat Narula, Patrick W. Serruys
JACC-CARDIOVASCULAR INTERVENTIONS
(2023)